Global Point of care testing Market Size study, by product (Glucose Monitoring Products, Infectious Disease Testing Products, Cardiometabolic Testing Products, Pregnancy & Fertility Testing Products, Coagulation Testing Products, Tumor/Cancer Marker Testing Products, Pregnancy & Fertility Testing Products, Cholesterol Testing Products, Urinalysis Testing Products, Drugs-of-Abuse Testing Products, Hematology Testing Products, Fecal Occult Testing Products and other POC products ), Platform (Microfluidics, Lateral Flow Assays, Dipsticks, immunoassays, molecular diagnostics) , Mode (OTC-based testing and prescription-based testing) End-user (research laboratories, home care, professional diagnostics centers and other end-users) and Regional Forecasts 2018-2025
Global Point of care testing Market to reach USD 50.5 billion by 2025.
Global Point of care testing market valued approximately USD 23.6 billion in 2017 is anticipated to grow with a healthy growth rate of more than 10.0% over the forecast period 2018-2025. Healthcare decentralization coupled with the technological advancements are considered as the key growth trends for the global point of care testing market over the forecast period.
Key driving factors for the point of care testing market are high prevalence of chronic and infectious diseases along with the government support to promote point of care testing. According to the fight chronic disease organization in 2015, in U.S. 133 million deaths are caused and disability due to chronic diseases. It is estimated that 45% Americans populations are suffering from at least one chronic disease. Since point of care testing is a faster and efficient diagnostic test that offers better monitoring, diagnosis, disease management. As a result, the adoption and demand for point of care testing products would increase thereby, supplementing the growth of the market over the forecast period. Furthermore, growing awareness of point-of-care testing offers lucrative growth prospects for the point of care testing market across the globe. However, stringent government policies are expected to hinder the growth of the market during the forecast period.
On the basis of segmentation, the point of care testing market is segmented into product, platform, mode and end-user. The product segment of global point of care testing market is classified into Glucose Monitoring Products, Infectious Disease Testing Products, Cardiometabolic Testing Products, Pregnancy & Fertility Testing Products, Coagulation Testing Products, Tumor/Cancer Marker Testing Products, Pregnancy & Fertility Testing Products, Cholesterol Testing Products, Urinalysis Testing Products, Drugs-of-Abuse Testing Products, Hematology Testing Products, Fecal Occult Testing Products and other POC products of which glucose monitoring testing products accounts the largest share owing to the increasing prevalence of diabetes. On the basis of platform, the market is diversified into microfluidics, lateral flow assays, dipsticks, immunoassays, molecular diagnostics. The end-user segment is classified into research laboratories, home care, professional diagnostics centers and other end-users. Also, the mode segment is bifurcated into OTC-based testing and prescription-based testing.
The regional analysis of point of care testing market is considered for the key regions such as North America, Europe, Asia Pacific, Latin America and ROW. North America holds the leading position in point of care testing market owing to the high awareness amongst healthcare providers and patients regarding early disease diagnosis along with increasing healthcare expenditure. Whereas, Asia-Pacific is expected to emerge as the fastest growing region in terms of market share. The growth of Asia-Pacific is witnessed owing to companies engaged in exploiting the untapped opportunities.
The leading market players include-
By Product
Global Point of care testing market valued approximately USD 23.6 billion in 2017 is anticipated to grow with a healthy growth rate of more than 10.0% over the forecast period 2018-2025. Healthcare decentralization coupled with the technological advancements are considered as the key growth trends for the global point of care testing market over the forecast period.
Key driving factors for the point of care testing market are high prevalence of chronic and infectious diseases along with the government support to promote point of care testing. According to the fight chronic disease organization in 2015, in U.S. 133 million deaths are caused and disability due to chronic diseases. It is estimated that 45% Americans populations are suffering from at least one chronic disease. Since point of care testing is a faster and efficient diagnostic test that offers better monitoring, diagnosis, disease management. As a result, the adoption and demand for point of care testing products would increase thereby, supplementing the growth of the market over the forecast period. Furthermore, growing awareness of point-of-care testing offers lucrative growth prospects for the point of care testing market across the globe. However, stringent government policies are expected to hinder the growth of the market during the forecast period.
On the basis of segmentation, the point of care testing market is segmented into product, platform, mode and end-user. The product segment of global point of care testing market is classified into Glucose Monitoring Products, Infectious Disease Testing Products, Cardiometabolic Testing Products, Pregnancy & Fertility Testing Products, Coagulation Testing Products, Tumor/Cancer Marker Testing Products, Pregnancy & Fertility Testing Products, Cholesterol Testing Products, Urinalysis Testing Products, Drugs-of-Abuse Testing Products, Hematology Testing Products, Fecal Occult Testing Products and other POC products of which glucose monitoring testing products accounts the largest share owing to the increasing prevalence of diabetes. On the basis of platform, the market is diversified into microfluidics, lateral flow assays, dipsticks, immunoassays, molecular diagnostics. The end-user segment is classified into research laboratories, home care, professional diagnostics centers and other end-users. Also, the mode segment is bifurcated into OTC-based testing and prescription-based testing.
The regional analysis of point of care testing market is considered for the key regions such as North America, Europe, Asia Pacific, Latin America and ROW. North America holds the leading position in point of care testing market owing to the high awareness amongst healthcare providers and patients regarding early disease diagnosis along with increasing healthcare expenditure. Whereas, Asia-Pacific is expected to emerge as the fastest growing region in terms of market share. The growth of Asia-Pacific is witnessed owing to companies engaged in exploiting the untapped opportunities.
The leading market players include-
- Abbott Laboratories
- Siemens Healthineers
- Roche Diagnostics
- Becton, Dickinson and Company
- Quest Diagnostic
- Johnson & Johnson
- Danaher Corporation
- Siemens
- Accubiotech
- EKF Diagnostics
By Product
- Glucose Monitoring Products
- Infectious Disease Testing Products
- Cardiometabolic Testing Products
- Pregnancy & Fertility Testing Products
- Coagulation Testing Products
- Tumor/Cancer Marker Testing Products
- Cholesterol Testing Products
- Urinalysis Testing Products
- Drugs-of-Abuse Testing Products
- Hematology Testing Products
- Fecal Occult Testing Products
- Other POC products
- Microfluidics
- Lateral Flow Assays
- Dipsticks
- Immunoassays
- Molecular diagnostics
- OTC-based testing
- Prescription-based testing
- Research laboratories
- Home care
- Professional diagnostics centers
- Other End Users
- North America
- U.S.
- Canada
- Europe
- UK
- Germany
- ROE
- Asia Pacific
- China
- India
- Japan
- ROAPEC
- LAMEA
- Brazil
- Mexico
- ROW
- Middle East & Africa
- Historical year – 2015, 2016
- Base year – 2017
- Forecast period – 2018 to 2025
- Key Consulting Companies & Advisors
- Large, medium-sized, and small enterprises
- Venture capitalists
- Value-Added Resellers (VARs)
- Third-party knowledge providers
- Investment bankers
- Investors
CHAPTER 1. GLOBAL POINT OF CARE TESTING MARKET DEFINITION AND SCOPE
1.1. Research Objective
1.2. Market Definition
1.3. Scope of The Study
1.4. Years Considered for The Study
1.5. Currency Conversion Rates
1.6. Report Limitation
CHAPTER 2. RESEARCH METHODOLOGY
2.1. Research Process
2.1.1. Data Mining
2.1.2. Analysis
2.1.3. Market Estimation
2.1.4. Validation
2.1.5. Publishing
2.2. Research Assumption
CHAPTER 3. EXECUTIVE SUMMARY
3.1. Global & Segmental Market Estimates & Forecasts, 2015-2025 (USD Billion)
3.2. Key Trends
CHAPTER 4. GLOBAL POINT OF CARE TESTING MARKET DYNAMICS
4.1. Growth Prospects
4.1.1. Drivers
4.1.2. Restraints
4.1.3. Opportunities
4.2. Industry Analysis
4.2.1. Porter’s 5 Force Model
4.2.2. PEST Analysis
4.2.3. Value Chain Analysis
4.3. Analyst Recommendation & Conclusion
CHAPTER 5. GLOBAL POINT OF CARE TESTING MARKET, BY PRODUCT
5.1. Market Snapshot
5.2. Market Performance - Potential Model
5.3. Global Point of care testing Market, Sub Segment Analysis
5.3.1. Glucose Monitoring Products
5.3.1.1. Market estimates & forecasts, 2015-2025 (USD Billion)
5.3.1.2. Regional breakdown estimates & forecasts, 2015-2025 (USD Billion)
5.3.2. Infectious Disease Testing Products
5.3.2.1. Market estimates & forecasts, 2015-2025 (USD Billion)
5.3.2.2. Regional breakdown estimates & forecasts, 2015-2025 (USD Billion)
5.3.3. Pregnancy and Fertility Testing Products
5.3.3.1. Market estimates & forecasts, 2015-2025 (USD Billion)
5.3.3.2. Regional breakdown estimates & forecasts, 2015-2025 (USD Billion)
5.3.4. Coagulation Testing Products
5.3.4.1. Market estimates & forecasts, 2015-2025 (USD Billion)
5.3.4.2. Regional breakdown estimates & forecasts, 2015-2025 (USD Billion)
5.3.5. Hematology Testing Products
5.3.5.1. Market estimates & forecasts, 2015-2025 (USD Billion)
5.3.5.2. Regional breakdown estimates & forecasts, 2015-2025 (USD Billion)
5.3.6. Drug of abuse Testing Products
5.3.6.1. Market estimates & forecasts, 2015-2025 (USD Billion)
5.3.6.2. Regional breakdown estimates & forecasts, 2015-2025 (USD Billion)
5.3.7. Urinalysis Testing Products
5.3.7.1. Market estimates & forecasts, 2015-2025 (USD Billion)
5.3.7.2. Regional breakdown estimates & forecasts, 2015-2025 (USD Billion)
5.3.8. Cholesterol Testing Products
5.3.8.1. Market estimates & forecasts, 2015-2025 (USD Billion)
5.3.8.2. Regional breakdown estimates & forecasts, 2015-2025 (USD Billion)
5.3.9. Fecal Occult Blood Testing products
5.3.9.1. Market estimates & forecasts, 2015-2025 (USD Billion)
5.3.9.2. Regional breakdown estimates & forecasts, 2015-2025 (USD Billion)
5.3.10. Tumor Marker Testing products
5.3.10.1. Market estimates & forecasts, 2015-2025 (USD Billion)
5.3.10.2. Regional breakdown estimates & forecasts, 2015-2025 (USD Billion)
5.3.11. Other POC products
5.3.11.1. Market estimates & forecasts, 2015-2025 (USD Billion)
5.3.11.2. Regional breakdown estimates & forecasts, 2015-2025 (USD Billion)
CHAPTER 6. GLOBAL POINT OF CARE TESTING MARKET, BY PLATFORM
6.1. Market Snapshot
6.2. Market Performance - Potential Model
6.3. Global Point of care testing Market, Sub Segment Analysis
6.3.1. Dipsticks
6.3.1.1. Market estimates & forecasts, 2015-2025 (USD Billion)
6.3.1.2. Regional breakdown estimates & forecasts, 2015-2025 (USD Billion)
6.3.2. Lateral Flow Assays
6.3.2.1. Market estimates & forecasts, 2015-2025 (USD Billion)
6.3.2.2. Regional breakdown estimates & forecasts, 2015-2025 (USD Billion)
6.3.3. Molecular diagnostics
6.3.3.1. Market estimates & forecasts, 2015-2025 (USD Billion)
6.3.3.2. Regional breakdown estimates & forecasts, 2015-2025 (USD Billion)
6.3.4. Microfluidics
6.3.4.1. Market estimates & forecasts, 2015-2025 (USD Billion)
6.3.4.2. Regional breakdown estimates & forecasts, 2015-2025 (USD Billion)
6.3.5. Immunoassays
6.3.5.1. Market estimates & forecasts, 2015-2025 (USD Billion)
6.3.5.2. Regional breakdown estimates & forecasts, 2015-2025 (USD Billion)
CHAPTER 7. GLOBAL POINT OF CARE TESTING MARKET, BY END-USER
7.1. Market Snapshot
7.2. Market Performance - Potential Model
7.3. Global Point of care testing Market, Sub Segment Analysis
7.3.1. Professional Diagnostics Centers
7.3.1.1. Market estimates & forecasts, 2015-2025 (USD Billion)
7.3.1.2. Regional breakdown estimates & forecasts, 2015-2025 (USD Billion)
7.3.2. Research Laboratories
7.3.2.1. Market estimates & forecasts, 2015-2025 (USD Billion)
7.3.2.2. Regional breakdown estimates & forecasts, 2015-2025 (USD Billion)
7.3.3. Home Care
7.3.3.1. Market estimates & forecasts, 2015-2025 (USD Billion)
7.3.3.2. Regional breakdown estimates & forecasts, 2015-2025 (USD Billion)
7.3.4. Other End-users
7.3.4.1. Market estimates & forecasts, 2015-2025 (USD Billion)
7.3.4.2. Regional breakdown estimates & forecasts, 2015-2025 (USD Billion)
CHAPTER 8. GLOBAL POINT OF CARE TESTING MARKET, BY PRESCRIPTION MODE
8.1. Market Snapshot
8.2. Market Performance - Potential Model
8.3. Global Point of care testing Market, Sub Segment Analysis
8.3.1. Prescription-Based testing
8.3.1.1. Market estimates & forecasts, 2015-2025 (USD Billion)
8.3.1.2. Regional breakdown estimates & forecasts, 2015-2025 (USD Billion)
8.3.2. OTC Testing
8.3.2.1. Market estimates & forecasts, 2015-2025 (USD Billion)
8.3.2.2. Regional breakdown estimates & forecasts, 2015-2025 (USD Billion)
CHAPTER 9. GLOBAL POINT OF CARE TESTING MARKET, BY REGIONAL ANALYSIS
9.1. Point of care testing Market, Regional Market Snapshot (2015-2025)
9.2. North America Point of care testing Market Snapshot
9.2.1. U.S.
9.2.1.1. Market estimates & forecasts, 2015-2025 (USD Billion)
9.2.1.2. Diagnostics breakdown estimates & forecasts, 2015-2025 (USD Billion)
9.2.1.3. Mode breakdown estimates & forecasts, 2015-2025 (USD Billion)
9.2.1.4. End-user breakdown estimates & forecasts, 2015-2025 (USD Billion)
9.2.2. Canada
9.2.2.1. Market estimates & forecasts, 2015-2025 (USD Billion)
9.2.2.2. Diagnostics breakdown estimates & forecasts, 2015-2025 (USD Billion)
9.2.2.3. Mode breakdown estimates & forecasts, 2015-2025 (USD Billion)
9.2.2.4. End-user breakdown estimates & forecasts, 2015-2025 (USD Billion)
9.3. Europe Point of care testing Market Snapshot
9.3.1. U.K.
9.3.1.1. Market estimates & forecasts, 2015-2025 (USD Billion)
9.3.1.2. Product breakdown estimates & forecasts, 2015-2025 (USD Billion)
9.3.1.3. Prescription Mode breakdown estimates & forecasts, 2015-2025 (USD Billion)
9.3.1.4. Platform breakdown estimates & forecasts, 2015-2025 (USD Billion)
9.3.1.5. End-user breakdown estimates & forecasts, 2015-2025 (USD Billion)
9.3.2. Germany
9.3.2.1. Market estimates & forecasts, 2015-2025 (USD Billion)
9.3.2.2. Product breakdown estimates & forecasts, 2015-2025 (USD Billion)
9.3.2.3. Prescription Mode breakdown estimates & forecasts, 2015-2025 (USD Billion)
9.3.2.4. Platform breakdown estimates & forecasts, 2015-2025 (USD Billion)
9.3.2.5. End-user breakdown estimates & forecasts, 2015-2025 (USD Billion)
9.3.3. Rest of Europe
9.3.3.1. Market estimates & forecasts, 2015-2025 (USD Billion)
9.3.3.2. Product breakdown estimates & forecasts, 2015-2025 (USD Billion)
9.3.3.3. Prescription Mode breakdown estimates & forecasts, 2015-2025 (USD Billion)
9.3.3.4. Platform breakdown estimates & forecasts, 2015-2025 (USD Billion)
9.3.3.5. End-user breakdown estimates & forecasts, 2015-2025 (USD Billion)
9.4. Asia Point of care testing Market Snapshot
9.4.1. China
9.4.1.1. Market estimates & forecasts, 2015-2025 (USD Billion)
9.4.1.2. Product breakdown estimates & forecasts, 2015-2025 (USD Billion)
9.4.1.3. Prescription Mode breakdown estimates & forecasts, 2015-2025 (USD Billion)
9.4.1.4. Platform breakdown estimates & forecasts, 2015-2025 (USD Billion)
9.4.1.5. End-user breakdown estimates & forecasts, 2015-2025 (USD Billion)
9.4.2. India
9.4.2.1. Market estimates & forecasts, 2015-2025 (USD Billion)
9.4.2.2. Product breakdown estimates & forecasts, 2015-2025 (USD Billion)
9.4.2.3. Prescription Mode breakdown estimates & forecasts, 2015-2025 (USD Billion)
9.4.2.4. Platform breakdown estimates & forecasts, 2015-2025 (USD Billion)
9.4.2.5. End-user breakdown estimates & forecasts, 2015-2025 (USD Billion)
9.4.3. Japan
9.4.3.1. Market estimates & forecasts, 2015-2025 (USD Billion)
9.4.3.2. Product breakdown estimates & forecasts, 2015-2025 (USD Billion)
9.4.3.3. Prescription Mode breakdown estimates & forecasts, 2015-2025 (USD Billion)
9.4.3.4. Platform breakdown estimates & forecasts, 2015-2025 (USD Billion)
9.4.3.5. End-user breakdown estimates & forecasts, 2015-2025 (USD Billion)
9.4.4. Rest of Asia Pacific
9.4.4.1. Market estimates & forecasts, 2015-2025 (USD Billion)
9.4.4.2. Product breakdown estimates & forecasts, 2015-2025 (USD Billion)
9.4.4.3. Prescription Mode breakdown estimates & forecasts, 2015-2025 (USD Billion)
9.4.4.4. Platform breakdown estimates & forecasts, 2015-2025 (USD Billion)
9.4.4.5. End-user breakdown estimates & forecasts, 2015-2025 (USD Billion)
9.5. Latin America Point of care testing Market Snapshot
9.5.1. Brazil
9.5.1.1. Market estimates & forecasts, 2015-2025 (USD Billion)
9.5.1.2. Product breakdown estimates & forecasts, 2015-2025 (USD Billion)
9.5.1.3. Prescription Mode breakdown estimates & forecasts, 2015-2025 (USD Billion)
9.5.1.4. Platform breakdown estimates & forecasts, 2015-2025 (USD Billion)
9.5.1.5. End-user breakdown estimates & forecasts, 2015-2025 (USD Billion)
9.5.2. Mexico
9.5.2.1. Market estimates & forecasts, 2015-2025 (USD Billion)
9.5.2.2. Product breakdown estimates & forecasts, 2015-2025 (USD Billion)
9.5.2.3. Prescription Mode breakdown estimates & forecasts, 2015-2025 (USD Billion)
9.5.2.4. Platform breakdown estimates & forecasts, 2015-2025 (USD Billion)
9.5.2.5. End-user breakdown estimates & forecasts, 2015-2025 (USD Billion)
9.6. Rest of The World
9.6.1. Middle East and Africa
9.6.1.1. Market estimates & forecasts, 2015-2025 (USD Billion)
9.6.1.2. Product breakdown estimates & forecasts, 2015-2025 (USD Billion)
9.6.1.3. Prescription Mode breakdown estimates & forecasts, 2015-2025 (USD Billion)
9.6.1.4. Platform breakdown estimates & forecasts, 2015-2025 (USD Billion)
9.6.1.5. End-user breakdown estimates & forecasts, 2015-2025 (USD Billion)
CHAPTER 10. COMPETITIVE INTELLIGENCE
10.1. Company Market Share (Subject to Data Availability)
10.2. Top Market Strategies
10.3. Company Profiles
10.3.1. Abbott Laboratories
10.3.1.1. Overview
10.3.1.2. Financial (Subject to Data Availability)
10.3.1.3. Product Summary
10.3.1.4. Recent Developments
10.3.2. Siemens Healthineers
10.3.3. Roche Diagnostics
10.3.4. Becton, Dickinson and Company
10.3.5. Quest Diagnostic
10.3.6. Johnson & Johnson
10.3.7. Danaher Corporation
10.3.8. Siemens
10.3.9. Accubiotech
10.3.10. EKF Diagnostics
1.1. Research Objective
1.2. Market Definition
1.3. Scope of The Study
1.4. Years Considered for The Study
1.5. Currency Conversion Rates
1.6. Report Limitation
CHAPTER 2. RESEARCH METHODOLOGY
2.1. Research Process
2.1.1. Data Mining
2.1.2. Analysis
2.1.3. Market Estimation
2.1.4. Validation
2.1.5. Publishing
2.2. Research Assumption
CHAPTER 3. EXECUTIVE SUMMARY
3.1. Global & Segmental Market Estimates & Forecasts, 2015-2025 (USD Billion)
3.2. Key Trends
CHAPTER 4. GLOBAL POINT OF CARE TESTING MARKET DYNAMICS
4.1. Growth Prospects
4.1.1. Drivers
4.1.2. Restraints
4.1.3. Opportunities
4.2. Industry Analysis
4.2.1. Porter’s 5 Force Model
4.2.2. PEST Analysis
4.2.3. Value Chain Analysis
4.3. Analyst Recommendation & Conclusion
CHAPTER 5. GLOBAL POINT OF CARE TESTING MARKET, BY PRODUCT
5.1. Market Snapshot
5.2. Market Performance - Potential Model
5.3. Global Point of care testing Market, Sub Segment Analysis
5.3.1. Glucose Monitoring Products
5.3.1.1. Market estimates & forecasts, 2015-2025 (USD Billion)
5.3.1.2. Regional breakdown estimates & forecasts, 2015-2025 (USD Billion)
5.3.2. Infectious Disease Testing Products
5.3.2.1. Market estimates & forecasts, 2015-2025 (USD Billion)
5.3.2.2. Regional breakdown estimates & forecasts, 2015-2025 (USD Billion)
5.3.3. Pregnancy and Fertility Testing Products
5.3.3.1. Market estimates & forecasts, 2015-2025 (USD Billion)
5.3.3.2. Regional breakdown estimates & forecasts, 2015-2025 (USD Billion)
5.3.4. Coagulation Testing Products
5.3.4.1. Market estimates & forecasts, 2015-2025 (USD Billion)
5.3.4.2. Regional breakdown estimates & forecasts, 2015-2025 (USD Billion)
5.3.5. Hematology Testing Products
5.3.5.1. Market estimates & forecasts, 2015-2025 (USD Billion)
5.3.5.2. Regional breakdown estimates & forecasts, 2015-2025 (USD Billion)
5.3.6. Drug of abuse Testing Products
5.3.6.1. Market estimates & forecasts, 2015-2025 (USD Billion)
5.3.6.2. Regional breakdown estimates & forecasts, 2015-2025 (USD Billion)
5.3.7. Urinalysis Testing Products
5.3.7.1. Market estimates & forecasts, 2015-2025 (USD Billion)
5.3.7.2. Regional breakdown estimates & forecasts, 2015-2025 (USD Billion)
5.3.8. Cholesterol Testing Products
5.3.8.1. Market estimates & forecasts, 2015-2025 (USD Billion)
5.3.8.2. Regional breakdown estimates & forecasts, 2015-2025 (USD Billion)
5.3.9. Fecal Occult Blood Testing products
5.3.9.1. Market estimates & forecasts, 2015-2025 (USD Billion)
5.3.9.2. Regional breakdown estimates & forecasts, 2015-2025 (USD Billion)
5.3.10. Tumor Marker Testing products
5.3.10.1. Market estimates & forecasts, 2015-2025 (USD Billion)
5.3.10.2. Regional breakdown estimates & forecasts, 2015-2025 (USD Billion)
5.3.11. Other POC products
5.3.11.1. Market estimates & forecasts, 2015-2025 (USD Billion)
5.3.11.2. Regional breakdown estimates & forecasts, 2015-2025 (USD Billion)
CHAPTER 6. GLOBAL POINT OF CARE TESTING MARKET, BY PLATFORM
6.1. Market Snapshot
6.2. Market Performance - Potential Model
6.3. Global Point of care testing Market, Sub Segment Analysis
6.3.1. Dipsticks
6.3.1.1. Market estimates & forecasts, 2015-2025 (USD Billion)
6.3.1.2. Regional breakdown estimates & forecasts, 2015-2025 (USD Billion)
6.3.2. Lateral Flow Assays
6.3.2.1. Market estimates & forecasts, 2015-2025 (USD Billion)
6.3.2.2. Regional breakdown estimates & forecasts, 2015-2025 (USD Billion)
6.3.3. Molecular diagnostics
6.3.3.1. Market estimates & forecasts, 2015-2025 (USD Billion)
6.3.3.2. Regional breakdown estimates & forecasts, 2015-2025 (USD Billion)
6.3.4. Microfluidics
6.3.4.1. Market estimates & forecasts, 2015-2025 (USD Billion)
6.3.4.2. Regional breakdown estimates & forecasts, 2015-2025 (USD Billion)
6.3.5. Immunoassays
6.3.5.1. Market estimates & forecasts, 2015-2025 (USD Billion)
6.3.5.2. Regional breakdown estimates & forecasts, 2015-2025 (USD Billion)
CHAPTER 7. GLOBAL POINT OF CARE TESTING MARKET, BY END-USER
7.1. Market Snapshot
7.2. Market Performance - Potential Model
7.3. Global Point of care testing Market, Sub Segment Analysis
7.3.1. Professional Diagnostics Centers
7.3.1.1. Market estimates & forecasts, 2015-2025 (USD Billion)
7.3.1.2. Regional breakdown estimates & forecasts, 2015-2025 (USD Billion)
7.3.2. Research Laboratories
7.3.2.1. Market estimates & forecasts, 2015-2025 (USD Billion)
7.3.2.2. Regional breakdown estimates & forecasts, 2015-2025 (USD Billion)
7.3.3. Home Care
7.3.3.1. Market estimates & forecasts, 2015-2025 (USD Billion)
7.3.3.2. Regional breakdown estimates & forecasts, 2015-2025 (USD Billion)
7.3.4. Other End-users
7.3.4.1. Market estimates & forecasts, 2015-2025 (USD Billion)
7.3.4.2. Regional breakdown estimates & forecasts, 2015-2025 (USD Billion)
CHAPTER 8. GLOBAL POINT OF CARE TESTING MARKET, BY PRESCRIPTION MODE
8.1. Market Snapshot
8.2. Market Performance - Potential Model
8.3. Global Point of care testing Market, Sub Segment Analysis
8.3.1. Prescription-Based testing
8.3.1.1. Market estimates & forecasts, 2015-2025 (USD Billion)
8.3.1.2. Regional breakdown estimates & forecasts, 2015-2025 (USD Billion)
8.3.2. OTC Testing
8.3.2.1. Market estimates & forecasts, 2015-2025 (USD Billion)
8.3.2.2. Regional breakdown estimates & forecasts, 2015-2025 (USD Billion)
CHAPTER 9. GLOBAL POINT OF CARE TESTING MARKET, BY REGIONAL ANALYSIS
9.1. Point of care testing Market, Regional Market Snapshot (2015-2025)
9.2. North America Point of care testing Market Snapshot
9.2.1. U.S.
9.2.1.1. Market estimates & forecasts, 2015-2025 (USD Billion)
9.2.1.2. Diagnostics breakdown estimates & forecasts, 2015-2025 (USD Billion)
9.2.1.3. Mode breakdown estimates & forecasts, 2015-2025 (USD Billion)
9.2.1.4. End-user breakdown estimates & forecasts, 2015-2025 (USD Billion)
9.2.2. Canada
9.2.2.1. Market estimates & forecasts, 2015-2025 (USD Billion)
9.2.2.2. Diagnostics breakdown estimates & forecasts, 2015-2025 (USD Billion)
9.2.2.3. Mode breakdown estimates & forecasts, 2015-2025 (USD Billion)
9.2.2.4. End-user breakdown estimates & forecasts, 2015-2025 (USD Billion)
9.3. Europe Point of care testing Market Snapshot
9.3.1. U.K.
9.3.1.1. Market estimates & forecasts, 2015-2025 (USD Billion)
9.3.1.2. Product breakdown estimates & forecasts, 2015-2025 (USD Billion)
9.3.1.3. Prescription Mode breakdown estimates & forecasts, 2015-2025 (USD Billion)
9.3.1.4. Platform breakdown estimates & forecasts, 2015-2025 (USD Billion)
9.3.1.5. End-user breakdown estimates & forecasts, 2015-2025 (USD Billion)
9.3.2. Germany
9.3.2.1. Market estimates & forecasts, 2015-2025 (USD Billion)
9.3.2.2. Product breakdown estimates & forecasts, 2015-2025 (USD Billion)
9.3.2.3. Prescription Mode breakdown estimates & forecasts, 2015-2025 (USD Billion)
9.3.2.4. Platform breakdown estimates & forecasts, 2015-2025 (USD Billion)
9.3.2.5. End-user breakdown estimates & forecasts, 2015-2025 (USD Billion)
9.3.3. Rest of Europe
9.3.3.1. Market estimates & forecasts, 2015-2025 (USD Billion)
9.3.3.2. Product breakdown estimates & forecasts, 2015-2025 (USD Billion)
9.3.3.3. Prescription Mode breakdown estimates & forecasts, 2015-2025 (USD Billion)
9.3.3.4. Platform breakdown estimates & forecasts, 2015-2025 (USD Billion)
9.3.3.5. End-user breakdown estimates & forecasts, 2015-2025 (USD Billion)
9.4. Asia Point of care testing Market Snapshot
9.4.1. China
9.4.1.1. Market estimates & forecasts, 2015-2025 (USD Billion)
9.4.1.2. Product breakdown estimates & forecasts, 2015-2025 (USD Billion)
9.4.1.3. Prescription Mode breakdown estimates & forecasts, 2015-2025 (USD Billion)
9.4.1.4. Platform breakdown estimates & forecasts, 2015-2025 (USD Billion)
9.4.1.5. End-user breakdown estimates & forecasts, 2015-2025 (USD Billion)
9.4.2. India
9.4.2.1. Market estimates & forecasts, 2015-2025 (USD Billion)
9.4.2.2. Product breakdown estimates & forecasts, 2015-2025 (USD Billion)
9.4.2.3. Prescription Mode breakdown estimates & forecasts, 2015-2025 (USD Billion)
9.4.2.4. Platform breakdown estimates & forecasts, 2015-2025 (USD Billion)
9.4.2.5. End-user breakdown estimates & forecasts, 2015-2025 (USD Billion)
9.4.3. Japan
9.4.3.1. Market estimates & forecasts, 2015-2025 (USD Billion)
9.4.3.2. Product breakdown estimates & forecasts, 2015-2025 (USD Billion)
9.4.3.3. Prescription Mode breakdown estimates & forecasts, 2015-2025 (USD Billion)
9.4.3.4. Platform breakdown estimates & forecasts, 2015-2025 (USD Billion)
9.4.3.5. End-user breakdown estimates & forecasts, 2015-2025 (USD Billion)
9.4.4. Rest of Asia Pacific
9.4.4.1. Market estimates & forecasts, 2015-2025 (USD Billion)
9.4.4.2. Product breakdown estimates & forecasts, 2015-2025 (USD Billion)
9.4.4.3. Prescription Mode breakdown estimates & forecasts, 2015-2025 (USD Billion)
9.4.4.4. Platform breakdown estimates & forecasts, 2015-2025 (USD Billion)
9.4.4.5. End-user breakdown estimates & forecasts, 2015-2025 (USD Billion)
9.5. Latin America Point of care testing Market Snapshot
9.5.1. Brazil
9.5.1.1. Market estimates & forecasts, 2015-2025 (USD Billion)
9.5.1.2. Product breakdown estimates & forecasts, 2015-2025 (USD Billion)
9.5.1.3. Prescription Mode breakdown estimates & forecasts, 2015-2025 (USD Billion)
9.5.1.4. Platform breakdown estimates & forecasts, 2015-2025 (USD Billion)
9.5.1.5. End-user breakdown estimates & forecasts, 2015-2025 (USD Billion)
9.5.2. Mexico
9.5.2.1. Market estimates & forecasts, 2015-2025 (USD Billion)
9.5.2.2. Product breakdown estimates & forecasts, 2015-2025 (USD Billion)
9.5.2.3. Prescription Mode breakdown estimates & forecasts, 2015-2025 (USD Billion)
9.5.2.4. Platform breakdown estimates & forecasts, 2015-2025 (USD Billion)
9.5.2.5. End-user breakdown estimates & forecasts, 2015-2025 (USD Billion)
9.6. Rest of The World
9.6.1. Middle East and Africa
9.6.1.1. Market estimates & forecasts, 2015-2025 (USD Billion)
9.6.1.2. Product breakdown estimates & forecasts, 2015-2025 (USD Billion)
9.6.1.3. Prescription Mode breakdown estimates & forecasts, 2015-2025 (USD Billion)
9.6.1.4. Platform breakdown estimates & forecasts, 2015-2025 (USD Billion)
9.6.1.5. End-user breakdown estimates & forecasts, 2015-2025 (USD Billion)
CHAPTER 10. COMPETITIVE INTELLIGENCE
10.1. Company Market Share (Subject to Data Availability)
10.2. Top Market Strategies
10.3. Company Profiles
10.3.1. Abbott Laboratories
10.3.1.1. Overview
10.3.1.2. Financial (Subject to Data Availability)
10.3.1.3. Product Summary
10.3.1.4. Recent Developments
10.3.2. Siemens Healthineers
10.3.3. Roche Diagnostics
10.3.4. Becton, Dickinson and Company
10.3.5. Quest Diagnostic
10.3.6. Johnson & Johnson
10.3.7. Danaher Corporation
10.3.8. Siemens
10.3.9. Accubiotech
10.3.10. EKF Diagnostics